HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia
Yoshitaka Zaimoku(National Institutes of Health), Neal S. Young(National Heart Lung and Blood Institute), Xingmin Feng(National Heart Lung and Blood Institute), Holly Eager(National Institutes of Health), Lemlem Alemu(National Institutes of Health), Audrey Ai Chin Lee(National Institutes of Health Clinical Center), Emma M. Groarke(MACOM (United States)), Ruba Shalhoub(National Heart Lung and Blood Institute), Sachiko Kajigaya(National Heart Lung and Blood Institute), Colin O. Wu(National Heart Lung and Blood Institute), Bhavisha A. Patel(MACOM (United States)), Sharon Adams(National Institutes of Health Clinical Center), Willy A. Flegel(National Institutes of Health Clinical Center), Olga Julia Rios(National Institutes of Health), Diego Quinones Raffo(National Institutes of Health)
Cited by 54
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Mutations in <i>TERT,</i> the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
|New England Journal of Medicine|2005|717
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|653
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Danazol Treatment for Telomere Diseases
|New England Journal of Medicine|2016|401